Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Huber

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Respiration; International Review of Thoracic Diseases|September 17, 2002
Kinetics of 5-aminolevulinic acid-induced fluorescence in organ cultures of bronchial epithelium and tumorFernando Gamarra, Simon Wagner, Salah Al-Batran, et al.
Journal of Ethnopharmacology|January 24, 2026
Safety and anti-inflammatory activity of Gentiana lutea L. in human bronchial epithelial cell culturesJoanne Wildhaber, Bedia Begum Karakocak, Mauro Sousa de Almeida, et al.
The Journal of Biological Chemistry|May 31, 2007
Grb10 and active Raf-1 kinase promote Bad-dependent cell survivalSem Kebache, Josée Ash, Matthew G Annis, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 2, 2017
Clinical relevance of the M1b and M1c descriptors from the proposed TNM 8 classification of lung cancerAmanda Tufman, Kathrin Kahnert, Diego Kauffmann-Guerrero, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 8, 2018
How much primary tumor metabolic volume reduction is required to improve outcome in stage III NSCLC after chemoradiotherapy? A single-centre experienceOlarn Roengvoraphoj, Chukwuka Eze, Cherylina Wijaya, et al.
Deutsche Medizinische Wochenschrift (1946)|February 25, 2017
[Chemotherapy in the Elderly with Non-Small Cell Lung Cancer: A Non-Interventional, Prospective, Multicentric Observational Study]David Felix Heigener, Gert Hoeffken, Dieter Wuerflein, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 9, 2017
Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancerOlarn Roengvoraphoj, Cherylina Wijaya, Chukwuka Eze, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 16, 2018
Correction to: Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancerOlarn Roengvoraphoj, Cherylina Wijaya, Chukwuka Eze, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2013
Preselection based on clinical characteristics in German non-small-cell lung cancer patients screened for EML4-ALK translocationAmanda Laura Helen Tufman, Martin Edelmann, Fernando Gamarra, et al.
Oncotargets and Therapy|November 11, 2017
Frequency and clinical relevance of EGFR mutations and EML4-ALK translocations in octogenarians with non-small cell lung cancerAmanda Tufman, Kathrin Kahnert, Thomas Duell, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Respiration; International Review of Thoracic Diseases|September 17, 2002
Kinetics of 5-aminolevulinic acid-induced fluorescence in organ cultures of bronchial epithelium and tumorFernando Gamarra, Simon Wagner, Salah Al-Batran, et al.
Journal of Ethnopharmacology|January 24, 2026
Safety and anti-inflammatory activity of Gentiana lutea L. in human bronchial epithelial cell culturesJoanne Wildhaber, Bedia Begum Karakocak, Mauro Sousa de Almeida, et al.
The Journal of Biological Chemistry|May 31, 2007
Grb10 and active Raf-1 kinase promote Bad-dependent cell survivalSem Kebache, Josée Ash, Matthew G Annis, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 2, 2017
Clinical relevance of the M1b and M1c descriptors from the proposed TNM 8 classification of lung cancerAmanda Tufman, Kathrin Kahnert, Diego Kauffmann-Guerrero, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 8, 2018
How much primary tumor metabolic volume reduction is required to improve outcome in stage III NSCLC after chemoradiotherapy? A single-centre experienceOlarn Roengvoraphoj, Chukwuka Eze, Cherylina Wijaya, et al.
Deutsche Medizinische Wochenschrift (1946)|February 25, 2017
[Chemotherapy in the Elderly with Non-Small Cell Lung Cancer: A Non-Interventional, Prospective, Multicentric Observational Study]David Felix Heigener, Gert Hoeffken, Dieter Wuerflein, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 9, 2017
Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancerOlarn Roengvoraphoj, Cherylina Wijaya, Chukwuka Eze, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 16, 2018
Correction to: Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancerOlarn Roengvoraphoj, Cherylina Wijaya, Chukwuka Eze, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2013
Preselection based on clinical characteristics in German non-small-cell lung cancer patients screened for EML4-ALK translocationAmanda Laura Helen Tufman, Martin Edelmann, Fernando Gamarra, et al.
Oncotargets and Therapy|November 11, 2017
Frequency and clinical relevance of EGFR mutations and EML4-ALK translocations in octogenarians with non-small cell lung cancerAmanda Tufman, Kathrin Kahnert, Thomas Duell, et al.
Pageof 9